Statement Of Cash Flows [Abstract]

Fresenius Medical Care AG & Co. KGaA - Filing #6524128

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Dividends received, classified as operating activities	219,953 EUR	—	—	95,213 EUR	—	58,472 EUR	—
Interest paid, classified as operating activities	394,535 EUR	—	—	350,681 EUR	—	341,629 EUR	—
Interest received, classified as operating activities	88,217 EUR	—	—	67,663 EUR	—	73,170 EUR	—
Income taxes paid (refund), classified as operating activities	410,126 EUR	—	—	334,615 EUR	—	345,052 EUR	—
Cash flows from (used in) operating activities	2.628.801 EUR	—	—	2.167.379 EUR	—	2.489.498 EUR	—
Cash flows from (used in) investing activities [abstract]
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities	89,595 EUR	—	—	57,671 EUR	—	144,516 EUR	—
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities	102,363 EUR	—	—	105,641 EUR	—	129,081 EUR	—
Proceeds from sales of property, plant and equipment, classified as investing activities	16,138 EUR	—	—	36,205 EUR	—	24,424 EUR	—
Cash flows from (used in) investing activities	544,227 EUR	—	—	734,725 EUR	—	1.196.228 EUR	—
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities	1.858.529 EUR	—	—	1.617.360 EUR	—	1.024.382 EUR	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	72,607 EUR	—	—	23,162 EUR	—	131,228 EUR	—
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes	153,438 EUR	—	—	207,868 EUR	—	400,116 EUR	—
Cash and cash equivalents	—	1.403.492 EUR	1.273.787 EUR	—	1.481.655 EUR	—	1.081.539 EUR